Therapeutic Agents for High Unmet Medical Needs
Total Trials
1
As Lead Sponsor
0
As Collaborator
NCT02289300
A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients
Phase: Phase 2
Role: Collaborator
Start: Jan 31, 2020
Completion: Dec 31, 2021
Loading map...